Skip to main content
. 2023 Feb 2;29(5):337.e1–337.e5. doi: 10.1016/j.jtct.2023.01.025

Table 2.

Donor and Recipient COVID-19 Immunologic Exposures (Vaccination or Infection) Pre-transplantation

Parameter Donor SARS-CoV-2 Exposures (N = 53) Recipient SARS-CoV-2 Exposures (N = 53) Recipient Vaccination or Infection Between 3 and 6 mo Post-Transplantation) (N = 53)
Vaccination, n (%) 28 (52.83) 22 (41.51) 28 (51.85)
No vaccine, n (%) 24 (45.28) 25 (47.17) 25 (48.15)
Infection, n (%) 1 (1.87) 4 (7.55)* 0 (0)
Vaccine status unknown, n (%) 0 (0) 4 (7.55) 0 (0)
Time from last vaccine dose to  transplant, d, median (IQR) 122 (58.5, 159) 140 (97, 181) N/A

N/A indicates not applicable.

Two recipients had both vaccination and infection prior to transplantation.